Menu

赛诺菲喜保宁的用法用量

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

After receiving Sanofi, patients must read the instructions carefully to understand the characteristics and contraindications of the drug. Then follow your doctor's instructions and take the medication in the correct dosage. Do not take medication blindly. The usage and dosage for patients taking Sanofi Vigabatrin include: (1) Recommended dosage for adults: 2g per day, taken in divided doses. The dose should be increased according to the clinical effect at a rate of 0.5-1g per day to the maximum daily dose of 4g (or 50mg/kg per day), which is effective for complex partial seizures of epilepsy (with or without generalized tonic-clonic seizures). (2) Children - General usage: For children aged 3-9 years, the recommended dose is 1g per day, divided into 2 doses; for older children, 2g per day, divided into 2 doses. (3) West syndrome: The average oral dose is 100 mg/kg per day (range 50-150 mg/kg).

Vigabatrin (vigabatrin) was approved for marketing in the UK in 1989 and was approved by the US Food and Drug Administration in 2009 for the treatment of infantile spasms and refractory focal epilepsy, making it one of the first-choice drugs for the treatment of infantile spasms, especially in patients with tuberous sclerosis. Although Vigabatrin has not yet entered the Chinese market, many parents of children with infantile spasms purchase it through various channels. Due to the potential retinal toxic effects of vigabatrin, which can lead to peripheral visual field defects in children, many clinicians have certain concerns about its use.

Recommended related hot articles: /newsDetail/95635.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。